Advances in the genetics of progressive myoclonus epilepsy
- PMID: 11579433
- DOI: 10.1002/ajmg.1575
Advances in the genetics of progressive myoclonus epilepsy
Abstract
The genetic progressive myoclonus epilepsies (PMEs) are clinically characterized by the triad of stimulus sensitive myoclonus (segmental lightning like muscular jerks), epilepsy (grand mal and absences) and progressive neurologic deterioration (dementia, ataxia, and various neurologic signs depending on the cause). Etiologically heterogenous, PMEs are rare and mostly autosomal recessive disorders, with the exception of autosomal dominant dentatorubral-pallidoluysian atrophy and mitochondrial encephalomyopathy with ragged red fibers (MERRF). In the last five years, specific mutations have been defined in Lafora disease (gene for laforin or dual specificity phosphatase in 6q24), Unverricht-Lundborg disease (cystatin B in 21q22.3), Jansky-Bielschowsky ceroid lipofuscinoses (CLN2 gene for tripeptidyl peptidase 1 in 11q15), Finnish variant of late infantile ceroid lipofuscinoses (CLN5 gene in 13q21-32 encodes 407 amino acids with two transmembrane helices of unknown function), juvenile ceroid lipofuscinoses or Batten disease (CLN3 gene in 16p encodes 438 amino acid protein of unknown function), a subtype of Batten disease and infantile ceroid lipofuscinoses of the Haltia-Santavuori type (both are caused by mutations in palmitoyl-protein thiosterase gene at 1p32), dentadorubropallidoluysian atrophy (CAG repeats in a gene in 12p13.31) and the mitochondrial syndrome MERRF (tRNA Lys mutation in mitochondrial DNA). In this review, we cover mainly these rapid advances.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
The molecular genetic bases of the progressive myoclonus epilepsies.Adv Neurol. 1999;79:383-98. Adv Neurol. 1999. PMID: 10514828 Review.
-
The autosomal recessively inherited progressive myoclonus epilepsies and their genes.Epilepsia. 2009 May;50 Suppl 5:29-36. doi: 10.1111/j.1528-1167.2009.02117.x. Epilepsia. 2009. PMID: 19469843 Review.
-
Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects.Lancet Neurol. 2005 Apr;4(4):239-48. doi: 10.1016/S1474-4422(05)70043-0. Lancet Neurol. 2005. PMID: 15778103 Review.
-
Progressive myoclonic epilepsy.Neurol India. 2010 Jul-Aug;58(4):514-22. doi: 10.4103/0028-3886.68660. Neurol India. 2010. PMID: 20739785 Review.
-
Progressive myoclonus epilepsies: EPM1, EPM2A, EPM2B.Adv Neurol. 2005;95:47-57. Adv Neurol. 2005. PMID: 15508913 Review. No abstract available.
Cited by
-
Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy.J Hum Genet. 2006;51(1):1-8. doi: 10.1007/s10038-005-0321-1. Epub 2005 Nov 26. J Hum Genet. 2006. PMID: 16311711 Review.
-
Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy.J Med Genet. 2006 Sep;43(9):e48. doi: 10.1136/jmg.2005.039479. J Med Genet. 2006. PMID: 16950819 Free PMC article.
-
An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice.J Biol Chem. 2021 Jan-Jun;296:100150. doi: 10.1074/jbc.RA120.015773. Epub 2020 Dec 10. J Biol Chem. 2021. PMID: 33277363 Free PMC article.
-
Discovery of a Novel Shared Variant Among RTEL1 Gene and RTEL1-TNFRSF6B lncRNA at Chromosome 20q13.33 in Familial Progressive Myoclonus Epilepsy.Int J Genomics. 2024 Aug 10;2024:7518528. doi: 10.1155/2024/7518528. eCollection 2024. Int J Genomics. 2024. PMID: 39156922 Free PMC article.
-
Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice.Exp Neurol. 2012 Jul;236(1):131-40. doi: 10.1016/j.expneurol.2012.04.008. Epub 2012 Apr 19. Exp Neurol. 2012. PMID: 22542948 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous